MedPath

Laparoscopic Assisted Versus Open Resection for Colorectal Carcinoma

Phase 3
Completed
Conditions
Colorectal Carcinoma
Registration Number
NCT00485316
Lead Sponsor
Chinese University of Hong Kong
Brief Summary

The aim of the investigators' randomized trial is to compare the short-term clinical outcome and survival between laparoscopic-assisted and open resection of colorectal carcinoma.

Detailed Description

Since the introduction of laparoscopic cholecystectomy in 1987, laparoscopic surgery has been attempted and applied to many surgical operations. Surgeons in Hong Kong began to perform laparoscopic surgery for colorectal carcinoma in early 1992. Early reports of laparoscopic surgery for colorectal carcinoma from Hong Kong and worldwide suggested better short-term clinical outcomes when compared with open surgery, but there were concerns over port site metastases and adequacy of long-term oncological clearance. Besides, only a few randomized trials thus far have compared laparoscopic-assisted and open surgery for rectal carcinoma.

The aim of our randomized trial is to compare the short-term clinical outcome and survival between laparoscopic-assisted and open resection of colonic and rectal carcinoma.

Patients will undergo different types of surgery according to the location of the tumors: right or extended right hemicolectomy for cecal, ascending colon, or hepatic flexure tumors; left hemicolectomy for descending colon tumors; sigmoid colectomy for sigmoid colon tumors; anterior resection for rectosigmoid or upper rectal tumors; low anterior resection with total mesorectal excision for mid- and low rectal tumors; abdominoperineal resection for very low rectal tumors. Patients will be randomly allocated to laparoscopic assisted or conventional open surgery.

Short-term clinical outcome and long-term survival data will be prospectively recorded and compared between the two treatment arms.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Patients diagnosed to have colorectal carcinoma at all locations except transverse colon
  • Informed consent available
Read More
Exclusion Criteria
  • Patients with tumor >6 cm in size, or with tumor infiltration to adjacent organs on imagings
  • Patients with previous abdominal surgery near the region of the colorectal surgery
  • Patients with intestinal obstruction or perforation
  • Patients with recurrent disease
  • Patients with synchronous colorectal carcinoma
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Overall survival and disease-free survival
Secondary Outcome Measures
NameTimeMethod
Postoperative analgesic requirements
Duration of hospital stay
Direct cost
Blood loss
Operative time
Time to walk independently
Morbidity and mortality
Recovery of gastrointestinal function (time to resume normal diet, time first passing flatus, time of first bowel motion)

Trial Locations

Locations (1)

Prince of Wales Hospital

🇨🇳

Hong Kong SAR, China

© Copyright 2025. All Rights Reserved by MedPath